Abstract:
A retrospective review was conducted of 44 consecutive patients treated at the National
University Hospital, Singapore with concurrent chemotherapy, and following ABS
guidelines for radiotherapy for definitive cervical cancer treatment beaten January 2001 and
January 2006. The median follow up time was 21 months, 5 year overall survival rate and
cause specific survival rate were 72.3 percent and 5 years DFS rate was 74.7 percent, The
commonest late toxicity was rectal toxicity. Grade 3 and 4 rectal or urinary toxicities were
rare. The commonest site of failure was in distant sited followed by loco-regional sites
